Vision changes are an inevitable part of aging, but why are some more susceptible to age-related eye diseases and why do some individuals experience more severe decline than others? New research from The Jackson Laboratory ...
Feb 18, 2025
0
0
There was a notable decrease in common ophthalmic procedures among Medicare beneficiaries during the first year of the COVID-19 pandemic, according to a study published Feb. 6 in JAMA Ophthalmology.
Feb 18, 2025
0
0
Our brain and eyes can play tricks on us—not least when it comes to the expanding hole illusion. A new computational model developed by Flinders University experts helps to explain how cells in the human retina make us ...
Feb 14, 2025
0
61
Researchers at the University of Toronto see a future where a single injection under the eyelid could replace months of daily eye drops to treat glaucoma, a leading cause of blindness.
Feb 14, 2025
0
61
Diabetic retinopathy is a severe complication of diabetes that can lead to blindness. The Japanese clinical practice guidelines for diabetes recommend that individuals undergo a fundus examination at least once a year to ...
Feb 14, 2025
0
0
Even when we think we are holding our gaze perfectly still, our eyes make tiny, involuntary movements. While these "fixational eye movements" might seem like they would blur our vision, new research reveals they actually ...
Feb 11, 2025
0
40
Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found. The University of Bristol-led study, published in Molecular Therapy, reveals how age ...
Feb 10, 2025
0
64
Graft-versus-host disease (GVHD) is a common and severe complication that occurs after stem cell transplantation, where the donor's immune cells attack the recipient's tissues. Ocular manifestation of GVHD is among the most ...
Feb 10, 2025
0
0
Years ago, a young patient's mother told Emily McCourt, MD, associate professor of ophthalmology at the University of Colorado School of Medicine, that she hadn't used a prescribed ointment to treat her baby's chemical corneal ...
Feb 8, 2025
0
30
The U.S. Food and Drug Administration has approved Genentech's Susvimo (ranibizumab) 100 mg/mL for treating diabetic macular edema.
Feb 6, 2025
0
0
